Page last updated: 2024-08-21

glycyrrhizic acid and Severe Acute Respiratory Syndrome

glycyrrhizic acid has been researched along with Severe Acute Respiratory Syndrome in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Ding, H; Hu, Y; Li, H; Li, S; Tang, H; Zhai, S; Zhao, R	1
Bauer, G; Chandra, P; Cinatl, J; Doerr, HW; Morgenstern, B; Rabenau, H	1
Chan, KH; Chen, F; Cheng, VC; Fan, KW; Guan, Y; Hung, IF; Jiang, Y; Kao, RY; Lee, TS; Lu, HT; Peiris, JS; Tsui, WH; Yuen, KY	1

Reviews

1 review(s) available for glycyrrhizic acid and Severe Acute Respiratory Syndrome

Article	Year
The Potential of Glycyrrhizinate in the Management of COVID-19: A Systematic Review of the Efficacy and Safety of Glycyrrhizin Preparations in the Treatment of SARS and MERS. The American journal of Chinese medicine, 2020, Volume: 48, Issue:7 Topics: Anti-Inflammatory Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glycyrrhizic Acid; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Treatment Outcome	2020

Article

Year

The Potential of Glycyrrhizinate in the Management of COVID-19: A Systematic Review of the Efficacy and Safety of Glycyrrhizin Preparations in the Treatment of SARS and MERS.

The American journal of Chinese medicine, 2020, Volume: 48, Issue:7

Topics: Anti-Inflammatory Agents; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Glycyrrhizic Acid; Humans; Middle East Respiratory Syndrome Coronavirus; Pandemics; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Treatment Outcome

2020

Other Studies

2 other study(ies) available for glycyrrhizic acid and Severe Acute Respiratory Syndrome

Article	Year
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet (London, England), 2003, Jun-14, Volume: 361, Issue:9374 Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Coronavirus; Glycyrrhiza; Glycyrrhizic Acid; Humans; Severe Acute Respiratory Syndrome; Vero Cells; Virus Replication	2003
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 31, Issue:1 Topics: Adult; Antiviral Agents; Cell Line; Chlorogenic Acid; Drug Synergism; Female; Flavonoids; Glycyrrhizic Acid; Humans; Interferon beta-1a; Interferon-alpha; Interferon-beta; Lopinavir; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidinones; Ribavirin; Rimantadine; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Plaque Assay	2004

Article

Year

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus.

Lancet (London, England), 2003, Jun-14, Volume: 361, Issue:9374

Topics: Animals; Antiviral Agents; Chlorocebus aethiops; Coronavirus; Glycyrrhiza; Glycyrrhizic Acid; Humans; Severe Acute Respiratory Syndrome; Vero Cells; Virus Replication

2003

In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2004, Volume: 31, Issue:1

Topics: Adult; Antiviral Agents; Cell Line; Chlorogenic Acid; Drug Synergism; Female; Flavonoids; Glycyrrhizic Acid; Humans; Interferon beta-1a; Interferon-alpha; Interferon-beta; Lopinavir; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidinones; Ribavirin; Rimantadine; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Plaque Assay

2004